Related Experiment Videos
Apoptosis: future directions in cancer therapy
D Ravi1, K R Panikkar, M K Nair
1Regional Cancer Centre, Kerala, India.
Abstract:
Cancer as a multifactorial disease results in gain of immortality due to defective apoptosis. The primary mode of cell death by apoptosis induced by various modes of treatment often fail in vivo. The in vitro environment is less complex while the in vivo environment is influenced by various external regulatory signals besides the existence of multiple, parallel and independent apoptotic pathways. Further, specific preference for an apoptotic pathway in a certain cell type would significantly alter the apoptotic responses. Identification of defects in preferred pathways and choosing alternative and potentially inducible pathways would help in deciding on apoptosis-based treatment protocols. Mechanisms involved in the execution of apoptosis may also not be unique to apoptotic pathways since similar events, possibly with strict control, do occur during mitosis. Further evaluation may yield new dimensions to apoptosis and apoptosis-based therapy.
Insights
Cancer cells evade apoptosis, a key cell death process, leading to immortality. Understanding and targeting specific apoptotic pathways, even those active in mitosis, is crucial for developing effective cancer treatments.
Area of Science:
- Cell Biology
- Oncology
- Molecular Biology
Background:
- Cancer is a multifactorial disease characterized by uncontrolled cell proliferation and evasion of programmed cell death (apoptosis).
- Therapeutic strategies targeting apoptosis often face challenges in the complex in vivo environment due to multiple parallel pathways and regulatory signals.
- Understanding the nuances of apoptosis in different cell types and conditions is critical for effective cancer therapy.
Purpose of the Study:
- To explore the complexities of apoptosis in cancer and its implications for treatment.
- To identify potential alternative or inducible apoptotic pathways for therapeutic intervention.
- To investigate the overlap between apoptotic mechanisms and mitotic processes.
Main Methods:
- The study reviews existing literature on apoptosis, cancer biology, and therapeutic resistance.
- It analyzes the differences between in vitro and in vivo models of apoptosis.
- The research discusses the role of specific apoptotic pathway preferences in different cell types.
Main Results:
- Defective apoptosis contributes to cancer cell immortality and treatment failure.
- The in vivo environment presents significant hurdles to apoptosis induction compared to in vitro settings.
- Cell-type specific apoptotic pathway preferences influence treatment outcomes.
Conclusions:
- Targeting defects in preferred apoptotic pathways or utilizing alternative inducible pathways can enhance apoptosis-based cancer treatments.
- Further research into the interplay between apoptosis and mitosis may reveal novel therapeutic strategies.
- A deeper understanding of apoptosis regulation is essential for advancing cancer therapy.